FEMASYS INC business relationships
Companies named in FEMASYS INC’s 10-K filed 2026-03-31, and public companies whose annual reports name FEMASYS INC. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 72 / 100 Top 1% in its category
- Agent readiness
- 30 / 100
- AI adoption
- 0 / 100
Named in FEMASYS INC’s annual report 2
“For the years ended December 31, 2025 and 2024, Bayer Yakuhin, Ltd. accounted for approximately 3% and 7%, respectively, of our total revenue.” SEC filing
“The Company sells products based on purchase orders provided by Bayer Yakuhin in accordance with their agreement.” SEC filing
Companies whose annual reports name FEMASYS INC 2
“| Collaboration Agreement, dated November 14, 2023, by and between PharmaCyte Biotech, Inc. and Femasys, Inc. |” SEC filing
“(the "Femasys Purchase Agreement") with Femasys Inc. ("Femasys"), pursuant to which we purchased from Femasys” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.